1012879-56-9

Basic information

• Product Name: 5-AMino-3-(2-fluorophenyl)-1-Methylpyrazole
• Synonyms: 5-AMino-3-(2-fluorophenyl)-1-Methylpyrazole;3-(2-fluorophenyl)-1-methyl-1H-Pyrazol-5-amine
• CAS NO: 1012879-56-9
• Molecular Formula: C₁₀H₁₀FN₃
• Molecular Weight: 191.2049032
• Mol File: 1012879-56-9.mol
• Article Data: 9

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5-AMino-3-(2-fluorophenyl)-1-Methylpyrazole(CAS DataBase Reference)
• NIST Chemistry Reference: 5-AMino-3-(2-fluorophenyl)-1-Methylpyrazole(1012879-56-9)
• EPA Substance Registry System: 5-AMino-3-(2-fluorophenyl)-1-Methylpyrazole(1012879-56-9)

Safety Data

• Hazardous Substances Data: 1012879-56-9(Hazardous Substances Data)

Usage

Uses

5-Amino-3-(2-fluorophenyl)-1-methylpyrazole is a versatile reactant used in the preparation of thiazolyl and oxazolyl urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors useful in the pain treatment.

Upstream product

• 31915-26-1 3-(2-fluorophenyl)-3-oxo-propanenitrile 
• 60-34-4 methylhydrazine 

Downstream Products

• 1312949-07-7 3-(2-fluorophenyl)-1-methyl-4-(trifluoromethyl)-1H-pyrazolo-[3,4-b]pyridin-6(7H)-one 
• 1312945-79-1 (S)-2-(3-(2-fluorophenyl)-1-methyl-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-6-yloxy)-N-(1-phenylethyl)acetamide 
• 1312949-10-2 2-(3-(2-fluorophenyl)-1-methyl-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-6-yloxy)acetic acid 
• 1312949-08-8 ethyl 2-(3-(2-fluorophenyl)-1-methyl-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-6-yloxy)acetate 

Relevant articles and documents

THIAZOLYL AND OXAZOLYL UREA, THIOUREA, GUANIDINE AND CYANOGUANIDINE COMPOUNDS AS TRKA KINASE INHIBITORS

Compounds of Formula (I) or stereoisomers, tautomers, or pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein Ring A, Ring C and X are as defined herein, are inhibitors of TrkA kinase and are useful in the treatment of diseases which can be treated with a TrkA kinase inhibitor such as pain, cancer, inflammation, neurodegenerative diseases, certain infectious diseases, Sjogren's syndrome, endometriosis, diabetic peripheral neuropathy, prostatitis or pelvic pain syndrome.

BICYCLIC HETEROARYL UREA, THIOUREA, GUANIDINE AND CYANOGUANIDINE COMPOUNDS AS TRKA KINASE INHIBITORS

Compounds of Formula I or stereoisomers, tautomers, or pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein Ring A, Ring C and X are as defined herein, are inhibitors of TrkA kinase and are useful in the treatment of diseases which can be treated with a TrkA kinase inhibitor such as pain, cancer, inflammation/inflammatory diseases, neurodegenerative diseases, certain infectious diseases, Sjogren's syndrome, endometriosis, diabetic peripheral neuropathy, prostatitis and pelvic pain syndrome.

N-(ARYLALKYL)-N'-PYRAZOLYL-UREA, THIOUREA, GUANIDINE AND CYANOGUANIDINE COMPOUNDS AS TRKA KINASE INHIBITORS

Compounds of Formula I or stereoisomers, tautomers, or pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein Ring A, Ring C, X, Ra, Rb, Rc, Rd and n are as defined herein, are inhibitors of TrkA kinase and are useful in the treatment of diseases which can be treated with a TrkA kinase inhibitor such as pain, cancer, inflammation/inflammatory diseases, neurodegenerative diseases, certain infectious diseases, Sjogren's syndrome, endometriosis, diabetic peripheral neuropathy, prostatitis or pelvic pain syndrome.